Recombinant Hepatitis B VaccineA Review of its Immunogenicity and Protective Efficacy Against Hepatitis B

被引：0
|
作者：
Julie C. Adkins
Antona J. Wagstaff
机构：
[1] Adis International Limited,
来源：
BioDrugs | 1998年 / 10卷
关键词：
Adis International Limited; Geometric Mean Titre; Seroprotection Rate; Recombinant Hepatitis; Carrier Mother;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recombinant hepatitis B vaccine Engerix B® [Hep-B (Eng)] is a noninfectious subunit hepatitis B viral vaccine indicated for the active immunisation of adults, children and infants against hepatitis B virus infection. It contains hepatitis B surface antigen (HBsAg) which is produced by the yeast Saccharomyces cerevisiae by use of recombinant DNA technology.
引用
收藏
页码：137 / 158
页数：21
相关论文
共 50 条
  • [41] The Possible Protective Effect of Hepatitis B Vaccine against Lymphomas: A Systematic Review
    Lia, Lorenza
    Grima, Daniela
    Amici, Francesca
    Manzi, Linda
    Monaci, Alessandro
    La Torre, Giuseppe
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (15) : 1864 - 1872
  • [42] IMMUNOGENICITY OF 2 RECOMBINANT HEPATITIS-B VACCINES IN OLDER INDIVIDUALS
    TREADWELL, TL
    KEEFFE, EB
    LAKE, J
    READ, A
    FRIEDMAN, LS
    GOLDMAN, IS
    HOWELL, CD
    DEMEDINA, M
    SCHIFF, ER
    JENSEN, DM
    KOFF, RS
    AMERICAN JOURNAL OF MEDICINE, 1993, 95 (06): : 584 - 588
  • [43] IMMUNOGENICITY OF A RECOMBINANT-DNA HEPATITIS-B VACCINE IN NEONATES
    MEHEUS, A
    ALISJAHBANA, A
    VRANCKX, R
    SUKADI, A
    USMAN, A
    NGANTUNG, W
    SUGITA, E
    SAFARY, A
    ANDRE, F
    RENIERS, J
    POSTGRADUATE MEDICAL JOURNAL, 1987, 63 : 139 - 141
  • [44] Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants
    Milne, A
    West, DJ
    Van Chinh, D
    Moyes, CD
    Poerschke, G
    JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (03) : 327 - 333
  • [45] IMMUNOGENICITY AND EFFICACY TESTING IN CHIMPANZEES OF AN ORAL HEPATITIS-B VACCINE BASED ON LIVE RECOMBINANT ADENOVIRUS
    LUBECK, MD
    DAVIS, AR
    CHENGALVALA, M
    NATUK, RJ
    MORIN, JE
    MOLNARKIMBER, K
    MASON, BB
    BHAT, BM
    MIZUTANI, S
    HUNG, PP
    PURCELL, RH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) : 6763 - 6767
  • [46] IMMUNOGENICITY AND PROTECTIVE EFFICACY OF LOW-DOSE RECOMBINANT-DNA HEPATITIS-B VACCINE IN NORMAL AND HIGH-RISK NEONATES
    ASSATEERAWATT, A
    TANPHAICHITR, VS
    SUVATTE, V
    INNGARM, L
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1991, 9 (02): : 89 - 93
  • [47] Immunogenicity of recombinant hepatitis B (HepB) and inactivated hepatitis A (HepA) vaccines in cystic fibrosis (CF) patients
    De Schutter, L.
    De Wachter, E.
    Hauser, B.
    Anckaert, E.
    Malfroot, A.
    PEDIATRIC PULMONOLOGY, 2007, : 384 - 384
  • [48] Immunisation against Hepatitis A, Hepatitis B and Typhoid Fever via Combined VaccinationRationale, Immunogenicity and Reactogenicity
    Stephan Proell
    BioDrugs, 2003, 17 : 7 - 10
  • [49] IMMUNOGENICITY OF HEPATITIS-B VACCINES
    NEEDLES, CF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (03): : 201 - 202
  • [50] VACCINATION AGAINST HEPATITIS-B IN A HEMATOLOGY-HEMOTHERAPY UNIT - STUDY OF ITS IMMUNOGENICITY
    HERNANDEZ, JM
    PIQUERAS, J
    ESTEBAN, JI
    ESTEBAN, R
    GUARDIA, J
    TRIGINER, J
    MEDICINA CLINICA, 1984, 82 (12): : 531 - 533
12345